Related Experiment Video
Updated: Jun 9, 2025
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
Harnessing bacterial metabolites for enhanced cancer chemotherapy: unveiling unique therapeutic potentials
Aroni Chatterjee1, Rajni Khan2, Triparna Mukherjee1
1Department of Biotechnology, School of Biotechnology and Biosciences, Brainware University, Barasat, Kolkata, 700125, West Bengal, India.
Abstract:
Cancer poses a serious threat to health globally, with millions diagnosed every year. According to Global Cancer Statistics 2024, about 20 million new cases were reported in 2022, and 9.7 million people worldwide died of this condition. Advanced therapies include combination of one or more treatment procedures, depending on the type, stage, and particular genetic constitution of the cancer, which may include surgery, radiotherapy, chemotherapy, immunotherapy, hormone therapy, targeted therapy, and stem cell transplant. Also, awareness about lifestyle changes, preventive measures and screening at early stages has reduced the incidence of the disease; still, there is a major failure in controlling the incidence of cancer because of its complex and multifaceted nature. With increasing interest in bacterial metabolites as possible novel and effective treatment options in cancer therapy, their main benefits include not only direct anticancer effects but also the modulation of the immune system and potential for targeted and combination therapies. They can therefore be used in combination with chemotherapy, radiotherapy, or immunotherapy to improve outcomes or reduce side effects. Furthermore, nanoparticle-based delivery systems have the potential to enhance the potency and safety of anticancer drugs by providing improved stability, targeted release, and controlled delivery.
Insights
Bacterial metabolites offer novel cancer treatments, enhancing therapies like chemotherapy and immunotherapy. Nanoparticle delivery systems further improve drug efficacy and safety for better cancer patient outcomes.
Area of Science:
- Oncology
- Microbiology
- Nanotechnology
Background:
- Cancer is a global health crisis with millions diagnosed and dying annually.
- Current advanced cancer therapies are complex and not always sufficient due to cancer's multifaceted nature.
- Bacterial metabolites are emerging as promising therapeutic agents in cancer treatment.
Purpose of the Study:
- To explore the potential of bacterial metabolites in cancer therapy.
- To investigate the benefits of bacterial metabolites, including direct anticancer effects and immune modulation.
- To examine the role of nanoparticle-based delivery systems in enhancing anticancer drug efficacy and safety.
Main Methods:
- Review of current cancer statistics and treatment modalities.
- Analysis of research on bacterial metabolites for anticancer properties.
- Exploration of nanoparticle applications in drug delivery for cancer therapy.
Main Results:
- Bacterial metabolites demonstrate direct anticancer effects and modulate the immune system.
- These metabolites show potential for targeted and combination therapies with conventional treatments.
- Nanoparticle systems can improve the stability, targeted release, and controlled delivery of anticancer drugs.
Conclusions:
- Bacterial metabolites represent a novel and effective approach to cancer therapy.
- Combination therapies involving bacterial metabolites and nanoparticle delivery systems hold significant promise for improving cancer treatment outcomes and reducing side effects.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistant Cancers
01:27Tumor Immunotherapy
01:29Microorganisms in Medicine and Therapeutics
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...